BDSX Q2 2022 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$11M-7.9% YoY

Gross Profit

$7M63.7% margin

Operating Income

-$12M-106.2% margin

Net Income

-$16M-144.5% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+67.2%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$75M

Total Liabilities

$68M

Stockholders' Equity

$8M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$12M	-7.9%
Gross Profit	$7M	$5M	+45.2%
Operating Income	-$12M	-$11M	-9.8%
Net Income	-$16M	-$11M	-38.8%

Revenue Segments

Diagnostic Tests

$10M93%

Service

$744,0007%